BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 4158809)

  • 1. Platelet stickiness in multiple sclerosis.
    Caspary EA; Prineas J; Miller H; Field EJ
    Lancet; 1965 Nov; 2(7422):1108-9. PubMed ID: 4158809
    [No Abstract]   [Full Text] [Related]  

  • 2. Atromid and platelet adhesiveness in multiple sclerosis.
    Millac P; Caspary EA; Prineas J
    J Atheroscler Res; 1967; 7(3):397-400. PubMed ID: 5340971
    [No Abstract]   [Full Text] [Related]  

  • 3. A comparison of platelet stickiness tests during an atromid-S trial.
    O'Brien JR; Heywood JB
    Thromb Diath Haemorrh; 1966 Dec; 16(3):768-77. PubMed ID: 5996687
    [No Abstract]   [Full Text] [Related]  

  • 4. Fibrinolytic activity of venous blood of patients with multiple sclerosis.
    Menon IS; Dewar HA; Newell DJ
    Neurology; 1969 Jan; 19(1):101-4. PubMed ID: 4886662
    [No Abstract]   [Full Text] [Related]  

  • 5. [Atromid].
    Borchgrevink CF
    Tidsskr Nor Laegeforen; 1967 Mar; 87(5):334. PubMed ID: 6039533
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of hyperlipidemia with the ethyl-ester of chlorophenoxyisobutyrate and androsterone.
    Schatz IJ
    Henry Ford Hosp Med J; 1965 Dec; 13(4):447-56. PubMed ID: 5325188
    [No Abstract]   [Full Text] [Related]  

  • 7. [The therapeutic use of CPIB in pathological increase of the lipid constituents of the blood].
    Cloarec M; Cottet J; Etienne J; Loeper J
    Sem Ther; 1965 Nov; 41(9):499-500. PubMed ID: 5877602
    [No Abstract]   [Full Text] [Related]  

  • 8. Clofibrate in glaucoma.
    Orbán T
    Lancet; 1968 Jan; 1(7532):47. PubMed ID: 4169091
    [No Abstract]   [Full Text] [Related]  

  • 9. Hypolipidemic agents--newly approved.
    Duncan GG
    Pa Med; 1967 Aug; 70(8):75-6. PubMed ID: 6073724
    [No Abstract]   [Full Text] [Related]  

  • 10. [The effect of ethyl-chlorophenoxyisobutyrate on the serum lipids in coronary sclerosis].
    Keller L; Rétsági G; Sebestyén M; Diczendy S; Erdélyi G
    Z Gesamte Inn Med; 1966 Mar; 21(6):169-72. PubMed ID: 5988081
    [No Abstract]   [Full Text] [Related]  

  • 11. [CPIB: a hypolipidemic agent. Study of 20 patients].
    Verdy M
    Union Med Can; 1966 Sep; 95(9):1049-52. PubMed ID: 5913817
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of Atromid on blood lipids in patients with hyperlipemia].
    Baranova LV
    Ter Arkh; 1968 Mar; 40(3):15-20. PubMed ID: 4875984
    [No Abstract]   [Full Text] [Related]  

  • 13. [Experience with 110 medium-length therapeutic trials of ethyl chlorophenoxyisobutyrate with or without androsterone in various types of idiopathic hyperlipidemia].
    De Gennes JL; Maunand B; Salmon D; Laudat P; Truffert J
    Rev Atheroscler (Paris); 1966; 8(1):27-52. PubMed ID: 5961027
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical experimentation with CPIB (with or without androsterone) in the treatment of hyperlipemia. Apropos of 35 cases].
    Warembourg H; Jaillard J
    Lille Med; 1965 Apr; 10(4):431-6. PubMed ID: 5318637
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of atromide on some indices of the lipid metabolism in hypercholesterinemic patients].
    Baranova LV
    Kardiologiia; 1965; 5(4):65-6. PubMed ID: 5880736
    [No Abstract]   [Full Text] [Related]  

  • 16. The effect of clofibrate on open-angle glaucoma.
    Marrs JM; Rowe KW
    Arch Ophthalmol; 1969 Jul; 82(1):19-20. PubMed ID: 5791497
    [No Abstract]   [Full Text] [Related]  

  • 17. [Action mechanism and clinical success of Regelan (Clofibrate)].
    Fitzgerald JD
    Wien Klin Wochenschr; 1967 Sep; 79(39):716-20. PubMed ID: 5595437
    [No Abstract]   [Full Text] [Related]  

  • 18. [Action of a 2.2 percent solution of androsterone, in chlorphenisate, on the serum lipoproteins of low density (LDL) in patients resistant to diet therapy].
    Bertolami V; Schneiderman B; Finatti AA; Netto RF
    Arq Bras Cardiol; 1966 Apr; 19(2):111-26. PubMed ID: 5943772
    [No Abstract]   [Full Text] [Related]  

  • 19. Hypolipidemic effect of chlorophenoxyisobutyrate in adult-onset diabetes mellitus.
    Danowski TS; Novak JF; Saul RW; Vester JW; Moses C
    Clin Pharmacol Ther; 1966; 7(5):631-8. PubMed ID: 5957168
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical trial with ethyl-a-p-chlorophenoxyisobutyrate (Atromid-S) with special reference to white blood cell counts.
    Engström J
    Acta Med Scand; 1966 Nov; 180(5):519-31. PubMed ID: 5332263
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.